Macquarie Uni backs biotech spin-off in $2 million Seed raise
A biotech startup using gene therapy to tackle neurodegenerative diseases such as Motor Neurone Disease (MND), epilepsy and dementia, has been spun out of Macquarie University with $2 million in Seed funding to launch. Celosia Therapeutics is Australia’s first gene therapy company and the result of two decades of research at the university. It is… Read more »